Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for Chronic Pain in Endometriosis
NCT06161805Phase 3Recruiting
- Sponsor
- Reinier de Graaf Hospital
- Start
- Mar 2024
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of esketamine in endometriosis, sponsored by Reinier de Graaf Hospital. Started Mar 2024; status: recruiting.
02
Drugs
esketamine
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT06161805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06161805.